You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
四環醫藥(00460.HK):婦科敷料類產品獲醫療器械註冊證
格隆匯 03-07 07:09

格隆匯3月7日丨四環醫藥(00460.HK)發佈公吿,集團旗下渼顏空間生物科技(吉林)有限公司所研發的共八款婦科敷料類產品獲得中國國家藥品監督管理局頒發的醫療器械註冊證。

本次獲批的婦科敷料類產品包括醫用婦科抗菌凝膠敷料,醫用婦科護理凝膠,卡波姆陰道凝膠,卡波姆婦科凝膠,醫用陰道阻菌液體敷料,醫用婦科沖洗液體敷料,醫用陰道阻菌凝膠及醫用婦科引導填塞敷料。八款產品均為II類醫療器械,可通過在陰道壁形成一層保護性凝膠膜,從而阻止病原微生物定植,有促進陰道自淨及創面癒合的作用。渼顏空間自研的八款婦科敷料類產品着重於協助解決婦科感染以及私密醫美術後的感染問題,不僅能通過適合、安全、無刺激的輔助讓術後效果更理想,也與集團其他私密產品,包括獨家代理的韓國東方醫療株式會社旗下的無張力尿道懸吊帶,具備很好的協同效用,在年內上市後能夠形成有效且互補的產品組合。

根據IQVIA數據顯示,2021年中國婦科抗感染外用藥等級醫院市場規模為人民幣54.2 億元,近5年複合增長率10.7%。其中,化學制劑外用藥市場規模為人民幣38.4億元,近 5年複合增長率13.2%;其他製劑(凝膠、敷料等)市場規模為668萬元,近5年複合增長率18.8%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account